Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
source: ClinicalTrials.govlicence: US NLM public datadatabase: /home/dbs/health.dbmode: tablerecords: 612567 (max_rowid)citation: https://clinicaltrials.gov/
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Fields
| status | NOT_YET_RECRUITING |
|---|---|
| phase | ['PHASE1'] |
| study_type | INTERVENTIONAL |
| countries | United States |
| sponsor | City of Hope Medical Center |
| start_date | 2027-10-13 |
| completion_date | 2028-10-13 |
source: ClinicalTrials.govlicence: US NLM public datayear: —id: NCT07914166citation: https://clinicaltrials.gov/study/NCT07914166